cas 867312-01-4|| where to buy 2-[(4Z)-4-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-2,5-dioxoimidazolidin-1-yl]-N-[3-(trifluoromethyl)phenyl]acetamide

Nombre del producto:2-[(4Z)-4-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-2,5-dioxoimidazolidin-1-yl]-N-[3-(trifluoromethyl)phenyl]acetamide

IUPAC Name:2-[(4Z)-4-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-2,5-dioxoimidazolidin-1-yl]-N-[3-(trifluoromethyl)phenyl]acetamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 867312-01-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :867312-01-4; Fórmula molecular:C22H18F3N3O3; Punto de fusión:-; Código de sonrisas:C\C(\C=C1/NC(=O)N(CC(=O)NC2=CC(=CC=C2)C(F)(F)F)C1=O)=C/C1=CC=CC=C1; Densidad:

: Número de catálogo:CM826352; Peso molecular:429.4; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Imidazolidines; Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.; imidazolidine supplier; As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.